Comparison 24. Subgroup analysis for fluoxetine versus MAOIs or newer ADs: failure to complete ‐ total.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 follow‐up <6 weeks	1		Odds Ratio (M‐H, Random, 95% CI)	Subtotals only
1.1 Fluoxetine vs Moclobemide	1	70	Odds Ratio (M‐H, Random, 95% CI)	0.92 [0.31, 2.76]
2 follow‐up 6‐16 weeks	15		Odds Ratio (M‐H, Random, 95% CI)	Subtotals only
2.1 Fluoxetina vs Agomelatine	2	785	Odds Ratio (M‐H, Random, 95% CI)	1.22 [0.59, 2.49]
2.2 Fluoxetine vs Mirtazapine	3	301	Odds Ratio (M‐H, Random, 95% CI)	0.92 [0.51, 1.68]
2.3 Fluoxetine vs Moclobemide	6	651	Odds Ratio (M‐H, Random, 95% CI)	1.02 [0.68, 1.53]
2.4 Fluoxetine vs Reboxetine	4	764	Odds Ratio (M‐H, Random, 95% CI)	0.60 [0.44, 0.83]